TY  - CONF

T1  - An evaluation of the clinical and cost-effectiveness of combination chemotherapy with gemcitabine plus paclitaxel for the treatment of metastatic breast cancer (MBC) in the UK from an NHS perspective.

JO  - BREAST CANCER RESEARCH AND TREATMENT

PY  - 2006/01/01

AU  - Bhalla S

AU  - Hibbert C

AU  - Chetty M

AU  - Poole C

AU  - Miles D

AU  - Coleman R

AU  - Bruce G

AU  - Beard S

AU  - Watkins J

ED  - 

VL  - 100

SP  - S232

EP  - S232

Y2  - 2025/10/10

ER  -